Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
4.600
-0.010 (-0.22%)
At close: May 12, 2025, 4:00 PM
4.600
0.00 (0.00%)
After-hours: May 12, 2025, 6:11 PM EDT
Amylyx Pharmaceuticals Market Cap
Amylyx Pharmaceuticals has a market cap or net worth of $407.57 million as of May 12, 2025. Its market cap has increased by 218.79% in one year.
Market Cap
407.57M
Enterprise Value
204.89M
1-Year Change
218.79%
Ranking
Category
Stock Price
$4.60
Market Cap Chart
Since the IPO on January 7, 2022, Amylyx Pharmaceuticals's market cap has decreased from $1.07B to $407.57M, a decrease of -61.88%. That is a compound annual growth rate of -25.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 408.46M | 58.72% |
| Dec 31, 2024 | 257.35M | -74.11% |
| Dec 29, 2023 | 993.86M | -59.40% |
| Dec 30, 2022 | 2.45B | 128.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 660.42B |
| Johnson & Johnson | 370.58B |
| UnitedHealth Group | 348.35B |
| AbbVie | 328.13B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 229.36B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |